FYG

(2S,5R)-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide

Created:2018-04-25
Last modified:  2021-01-20

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count28
Chiral Atom Count3
Bond Count29
Aromatic Bond Count0
2D diagram of FYG
Toggle HydrogenToggle Labels

Chemical Component Summary

Name(2S,5R)-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
SynonymsAvibactam
Systematic Name (OpenEye OEToolkits)[(2~{S},5~{R})-2-aminocarbonyl-7-oxidanylidene-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate
FormulaC7 H11 N3 O6 S
Molecular Weight265.244
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESACDLabs12.01C(N)(C1CCC2CN1C(N2OS(=O)(O)=O)=O)=O
SMILESCACTVS3.385NC(=O)[CH]1CC[CH]2C[N]1C(=O)N2O[S](O)(=O)=O
SMILESOpenEye OEToolkits2.0.6C1CC(N2CC1N(C2=O)OS(=O)(=O)O)C(=O)N
Canonical SMILESCACTVS3.385 NC(=O)[C@@H]1CC[C@@H]2C[N@]1C(=O)N2O[S](O)(=O)=O
Canonical SMILESOpenEye OEToolkits2.0.6 C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)C(=O)N
InChIInChI1.03 InChI=1S/C7H11N3O6S/c8-6(11)5-2-1-4-3-9(5)7(12)10(4)16-17(13,14)15/h4-5H,1-3H2,(H2,8,11)(H,13,14,15)/t4-,5+/m1/s1
InChIKeyInChI1.03 NDCUAPJVLWFHHB-UHNVWZDZSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
DrugBank IDDB09060 
NameAvibactam
Groups
  • approved
  • investigational
DescriptionAvibactam is a non-β-lactam β-lactamase inhibitor that is available in combination with ceftazidime (Avycaz). This combination was approved by the FDA on February 25, 2015 for the treatment of complicated intra-abdominal infections in combination with metronidazole, and the treatment of complicated urinary tract infections, including pyelonephritis caused by antibiotic resistant-pathogens, including those caused by multi-drug resistant gram-negative bacterial pathogens. As there is limited clinical safety and efficacy data, Avycaz should be reserved for patients over 18 years old who have limited or not alternative treatment options.
Synonyms
  • Avibactam
  • Avibactam sodium
Brand Names
  • Avycaz
  • Emblaveo
  • Zavicefta
IndicationAvibactam as a combination product with [ceftazidime] (AVYCAZ) is indicated for: - In combination with [metronidazole], is indicated for the treatment of complicated intra-abdominal infections caused by the following susceptible microorganisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Providencia stuartii, Enterobacter cloacae, Klebsiella oxytoca, and Pseudomonas aeruginosa in adult and pediatric patients (at least 31 weeks gestational age). [L52435] - For the treatment of complicated urinary tract infections including pyelonephritis caused by the following susceptible microorganisms: Escherichia coli, Klebsiella pneumoniae, Citrobacter koseri, Enterobacter aerogenes, Enterobacter cloacae, Citrobacter freundii, Proteus spp., and Pseudomonas aeruginosa in adult and pediatric patients (at least 31 weeks gestational age). [L52435] - For the treatment of hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) in adult and pediatric patients (at least 31 weeks gestational age).[L52435] Avibactam as a combination product with [aztreonam] (EMBLAVEO) is indicated for: - In combination with [metronidazole], in patients 18 years and older who have limited or no alternative options for the treatment of complicated intra-abdominal infections (cIAI) including those caused by the following susceptible gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae complex, Citrobacter freundii complex, and Serratia marcescens. [L52460]
Categories
  • Anti-Infective Agents
  • Aza Compounds
  • beta-Lactamase Inhibitors
  • Enzyme Inhibitors
  • OAT3/SLC22A8 Substrates
CAS number1192500-31-4

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
Beta-lactamase TEMMSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLN...unknowninhibitor
Beta-lactamase CTX-MMVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGV...unknowninhibitor
Beta-lactamaseMMRKSLCCALLLGISCSALATPVSEKQLAEVVANTITPLMKAQSVPGMAV...unknowninhibitor
Beta-lactamase SHV-1MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASG...unknowninhibitor
Beta-lactamase SHV-2MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASG...unknowninhibitor
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 90333665, 9835049
ChEMBL CHEMBL1689063
ChEBI CHEBI:85984
CCDC/CSD FUBDUE, FUBDEO